Table 1.
Clinical characteristics of RNA-seq cohort
| Clinical Characteristic | Value (%) |
|---|---|
| FIGO stage | |
| IB1 | 1 (5) |
| IB2 | 4 (20) |
| IIB | 11 (55) |
| IIIB | 4 (20) |
| Nodal involvement on PET | |
| Pelvic | 10 (50) |
| Pelvic and Para-aortic | 1 (5) |
| None | 9 (45) |
| Histology | |
| Squamous | 19 (95) |
| Adenocarcinoma | 1 (5) |
| HPV type prior to CRT | |
| HPV 16 | 11 (55) |
| HPV 18 | 3 (15) |
| HPV 33 | 1 (5) |
| HPV 45 | 1 (5) |
| HPV 52 | 1 (5) |
| HPV 68 | 1 (5) |
| HPV negative | 2 (10) |
| Outcome | |
| Dead of disease (DOD) | 7 (35) |
| No Evidence of Disease (NED) | 13 (65) |